Medicines and Pregnancy, Labeling and Beyond, Sandra L. Kweder, MD, CDER .ppt .html

UPDATE: Nonclinical Reproductive Toxicity Information in Assessing Human Risk, Joseph DeGeorge PhD, CDER .ppt .html

NICHD Perspective on Needs for the Study of Therapeutic Drug Use in Pregnancy, Catherine Y Spong, MD, NIH .ppt .html

Pregnancy Follow-Up Studies, Lessons from Glaxo-Wellcome, Elizabeth Andrews, PhD, Glaxo-Wellcome, .ppt .html

Pregnancy Registry Working Group, Pregnancy Labeling Task Force, Evelyn Rodriguez, MD, CDER .ppt .html

Individual Privacy and the Public Health, Audrey Rogers, PhD .ppt .html